KATHMANDU: Nepal has been place to purchase four thousand doses of this Chinese Sinopharm vaccine because of its struggle the next wave of this Covid-19 pandemic, local press reported.
But details such as the cost and shipping date are kept under wraps.
The Kathmandu Post noted that the vaccines could be purchased below a non-disclosure arrangement, as suggested by Sinopharm, increasing concerns among a lot of individuals in the northeast state.
“The Cabinet has resisted the vaccine procurement component of the Ministry of Public Health to get four thousand doses of this vaccine in China,” Minister for Industry, Supplies and Commerce Rajkishwor Yadhav told the Post.
“Other problems including cost, logistics, transport is going to be considered from the government agencies involved” The Nepali daily paper reported that a ministry as saying two doses of both the Chinese vaccine are more most likely to cost approximately $20.
As reported by a nation’s health ministry official, $20 for 2 doses could continue to be expensive for Nepal compared to what bargain it obtained for the 4 AstraZeneca vaccine in the Serum Institute of India.
Last week, Bangladesh’d signed a deal with China to get the Sinopharm Covid-19 vaccine, without revealing the cost or volume of dosages, Dhaka Tribune reported.
This comes because the revelation of procurement cost of Sinopharm vaccine in Sri Lanka in May had ignited a row after reports surfaced that Colombo had to shell a greater per-dose cost compared to its South Asian state Bangladesh.
According to the Daily Mirror, Sri Lanka has been spending 15 per dose to its Sinopharm vaccine, and it will be $ 5 greater than that which Bangladesh paid.
Bangladesh had begun its inoculation push against coronavirus using all the Oxford-AstraZeneca vaccine obtained in India at $ 5 per serving.
As matters stand, the Chinese medication will be put to price Bangladesh twice click the AstraZeneca shot.
Nepal to Purchase 4 Thousand Chinese Covid-19 vaccine, non-disclosure deal raises Worries
